Position in CHRS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$18,270,872
-$2,500,580 QoQ
Shares Held
13,050,623
+6.2% QoQ
Ownership
8.45%
of shares outstanding
% of Portfolio
10.92%
of 13F equity value
Holder Rank
#1
of 145 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Timothy G. Youngquist 2020 Irrevocable Trust holds $46,702,441 across 5 Biotechnology names. CHRS ranks #1 (39.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CHRS |
Coherus Oncology, Inc.
This page
|
13,050,623 | $18,270,872 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
801,464 | $14,995,391 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
271,849 | $10,604,829 | |
| 4 | MLYS |
Mineralys Therapeutics, Inc.
|
100,869 | $2,721,445 | |
| 5 | CNTX |
Context Therapeutics Inc.
|
198,384 | $109,904 |
All Filings in CHRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,270,872 | 13,050,623 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $21,548,852 | 12,750,800 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $20,771,452 | 12,290,800 | Shares | Sole | 2026-08-07 | |
| 2026-02-05 | $0 | 0 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,371,395 | 5,895,349 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||